| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2025-08-25 | BAUMGARTNER ROBERT V | Director | Sale+OE | 17,040 | $56.21 | $957,818.40 | -27.5% | → |
| 2025-08-25 | Nusse Roeland | Director | Sale+OE | 17,040 | $56.36 | $960,388.03 | -27.7% | → |
| 2025-06-09 | Herr Amy E. | Director | Sale+OE | 1,280 | $49.77 | $63,704.83 | -39.3% | → |
| 2025-02-14 | Herr Amy E. | Director | Sale+OE | 1,860 | $65.96 | $122,690.62 | -48.5% | → |
| 2025-01-27 | Kelderman Kim | Chief Executive Officer | Sale+OE | 13,392 | $77.29 | $1,035,013.42 | -14.4% | → |
| 2024-08-08 | BAUMGARTNER ROBERT V | Director | Sale+OE | 16,000 | $72.10 | $1,153,664.00 | -26.9% | → |
| 2024-05-14 | HIGGINS JOHN L | Director | Sale+OE | 4,000 | $83.84 | $335,377.20 | -9.9% | → |
| 2024-03-07 | Nusse Roeland | Director | Sell | 10,400 | $76.98 | $800,627.36 | -19.4% | → |
| 2023-08-30 | Nusse Roeland | Director | Sale+OE | 8,939 | $80.32 | $717,959.03 | -14.7% | → |
| 2023-07-21 | Kummeth Charles R. | Chief Executive Officer | Sell | 80,000 | $88.36 | $7,069,024.00 | -6.0% | → |
| 2023-06-07 | Kummeth Charles R. | Chief Executive Officer | Sell | 322 | $83.00 | $26,726.00 | - | → |
| 2022-12-08 | Furlow Brenda S. | SVP - GENERAL COUNSEL | Sale+OE | 8,250 | $82.11 | $677,415.43 | -13.7% | → |
| 2022-08-11 | HIGGINS JOHN L | Director | Sale+OE | 2,504 | $378.80 | $948,516.15 | -7.4% | → |
| 2022-06-08 | HIGGINS JOHN L | - | Sale+OE | 1,600 | $364.98 | $583,964.00 | -14.8% | → |
| 2022-06-07 | Kummeth Charles R. | CHIEF EXECUTIVE OFFICER | Sale+OE | 5,104 | $365.00 | $1,862,960.00 | -2.5% | → |
| 2022-05-10 | BAUMGARTNER ROBERT V | - | Buy | 300 | $352.55 | $105,765.00 | +3.1% | → |
| 2021-11-19 | Kelderman Kim | Pres. Diagnostics & Genom | Sale+OE | 500 | $505.38 | $252,689.00 | -55.6% | → |
| 2021-11-12 | Eansor Norman David | President-Protein Sciences | Sale+OE | 27,159 | $504.00 | $13,688,192.94 | -13.2% | → |
| 2021-11-02 | Hippel James | Chief Financial Officer | Sale+OE | 9,022 | $526.49 | $4,749,989.78 | -12.6% | → |
| 2021-10-29 | Hippel James | Chief Financial Officer | Sale+OE | 762 | $525.23 | $400,222.05 | -3.4% | → |
| 2021-09-22 | Kelderman Kim | Pres. Diagnostics & Genom | Sell | 822 | $529.04 | $434,870.88 | -100% | → |
| 2021-09-07 | STEER RANDOLPH C | - | Sale+OE | 8,000 | $509.98 | $4,079,823.17 | -27.6% | → |
| 2021-09-02 | Furlow Brenda S. | SVP - General Counsel | Sale+OE | 6,871 | $509.94 | $3,503,764.17 | -29.0% | → |
| 2021-09-02 | Hippel James | Chief Financial Officer | Sale+OE | 10,000 | $507.22 | $5,072,164.68 | -31.5% | → |